BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program
07.08.2025 - 18:03:32 | prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/bioarctic-announces-global-license-agreement-with-bristol-myers-squibb-for-bioarctics-pyroglutamate-amyloid-beta-antibody-program-302335899.html
en | US1101221083 | BIOARCTIC | boerse | 67995695 |
